Literature DB >> 12527497

Portal vein thrombosis after radiofrequency ablation for recurrent hepatocellular carcinoma.

Kelvin Kwok-Chai Ng1, Chi-Ming Lam, Ronnie Tung-Ping Poon, Sheung-Tat Fan.   

Abstract

Recurrent hepatocellular carcinoma (HCC) deserves multidisciplinary treatment in addition to surgical resection. Radiofrequency ablation (RFA) is an evolving, localized, thermal ablative treatment for unresectable hepatocellular carcinoma (HCC). Though the preliminary results of RFA in clinical studies are encouraging, its serious complications should not be underestimated. Portal vein thrombosis as a result of direct blood vessel injury by RFA is rarely reported and is potentially fatal in patients with limited liver reserve due to underlying liver cirrhosis. We present a case of portal vein thrombosis as a complication of RFA treatment for recurrent HCC and illustrate its underlying possible mechanism.

Entities:  

Mesh:

Year:  2003        PMID: 12527497     DOI: 10.1016/S1015-9584(09)60218-9

Source DB:  PubMed          Journal:  Asian J Surg        ISSN: 1015-9584            Impact factor:   2.767


  3 in total

1.  Radiofrequency ablation of locally advanced pancreatic adenocarcinoma: an overview.

Authors:  Mirko D'Onofrio; Emilio Barbi; Roberto Girelli; Enrico Martone; Anna Gallotti; Roberto Salvia; Paolo-Tinazzi Martini; Claudio Bassi; Paolo Pederzoli; Roberto Pozzi Mucelli
Journal:  World J Gastroenterol       Date:  2010-07-28       Impact factor: 5.742

2.  Percutaneous Radiofrequency Ablation of Unresectable Locally Advanced Pancreatic Cancer: Preliminary Results.

Authors:  Mirko D'Onofrio; Stefano Crosara; Riccardo De Robertis; Giovanni Butturini; Roberto Salvia; Salvatore Paiella; Claudio Bassi; Roberto Pozzi Mucelli
Journal:  Technol Cancer Res Treat       Date:  2016-05-18

Review 3.  Percutaneous ablation of pancreatic cancer.

Authors:  Mirko D'Onofrio; Valentina Ciaravino; Riccardo De Robertis; Emilio Barbi; Roberto Salvia; Roberto Girelli; Salvatore Paiella; Camilla Gasparini; Nicolò Cardobi; Claudio Bassi
Journal:  World J Gastroenterol       Date:  2016-11-28       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.